If your stomach is unhappy on Wegovy, you're in the majority. Nearly three in four adults in its weight trials reported a digestive side effect, against about half on placebo [1]. Most of it is mild and temporary. A small part of it isn't, and the difference is worth knowing. The drug behind Wegovy is covered in semaglutide.
Wegovy nausea is most common while the dose is rising
The label doesn't give a duration, but it does say when digestive side effects cluster: “These reactions were most frequently reported during dosage escalation” [1]. In the STEP 1 trial, that escalation phase lasted the first 16 weeks before people reached the 2.4 mg maintenance dose [3]. Your own schedule is set by your prescriber.
A pooled analysis of the STEP 1 to 3 trials looked closer. In the semaglutide 2.4 mg group, the share of people with nausea, diarrhea or vomiting peaked at about week 20 and fell after that. Individual bouts were short: the median nausea episode lasted 8 days, diarrhea 3 days and vomiting 2 days, similar to how long the same symptoms lasted on placebo [2]. The authors described most episodes as mild to moderate and transient. Two of them are Novo Nordisk employees, and the trials were Novo's.
A median is the middle value, so half of episodes were shorter and half longer. And these are single episodes, not a whole course of treatment: the analysis counted episodes, so one person could have several.
Wegovy slows your stomach, which is part of how it works
The label states it plainly: “WEGOVY delays gastric emptying” [1]. This is one known action of the medicine; it does not by itself establish the cause of an individual’s nausea. Semaglutide also affects appetite. The label says its gradual dose-escalation schedule is intended to reduce gastrointestinal reactions.
Nausea is the most common, followed by diarrhea, vomiting and constipation
| Side effect | Wegovy 2.4 mg | Placebo |
|---|---|---|
| Any digestive side effect | 73% | 47% |
| Nausea | 44% | 16% |
| Diarrhea | 30% | 16% |
| Vomiting | 24% | 6% |
| Constipation | 24% | 11% |
| Stomach pain | 20% | 10% |
| Indigestion (dyspepsia) | 9% | 3% |
| Bloating (abdominal distension) | 7% | 5% |
| Burping (eructation) | 7% | under 1% |
| Gas (flatulence) | 6% | 4% |
| Stomach flu (gastroenteritis) | 6% | 4% |
| Reflux (GERD) | 5% | 3% |
| Gastritis | 4% | 1% |
| Severe digestive side effects | 4.1% | 0.9% |
| Stopped Wegovy because of digestive side effects | 4.3% | 0.7% |
Wegovy prescribing information, Table 3 and the digestive side-effect section (2,116 people on Wegovy, 1,261 on placebo) [1]. On the tablets, severe digestive side effects were reported by 2% vs 0% on placebo.
The label also lists hemorrhoids and hiccups as more common on Wegovy, without rates. In the separate adolescent trial, in the trial of children 12 and older, 62% on Wegovy reported a digestive side effect against 42% on placebo, with vomiting in 36% versus 10% [1]. The brand and its approved uses are covered in Wegovy. Zepbound has a similar pattern with its own numbers, covered in does Zepbound cause constipation.
About 1 in 4 adults had constipation, and it lasted longer than nausea
Constipation was reported by 24% on Wegovy and 11% on placebo [1]. It behaves differently from nausea. In the pooled analysis, a typical constipation episode lasted a median of 47 days, against 35 days on placebo, and the share of people affected leveled off around week 10 rather than falling [2].
Rarely, constipation becomes serious. After approval, reports came in of “ileus, intestinal obstruction, severe constipation including fecal impaction” with semaglutide [1]. These come from voluntary reports, so there's no rate. If constipation is severe, or comes with vomiting, a swollen belly or stomach pain, call your prescriber promptly.
Heartburn, gas and bloating are common too
Reflux (5% vs 3%), gas (6% vs 4%), bloating (7% vs 5%) and burping (7% vs under 1%) were all more common on Wegovy [1]. Burping stands out because it almost never happened on placebo. The label doesn't say how long heartburn lasts, so if it's sticking around, that's a question for your prescriber.
For most people it gets better, but not for everyone
Most people stay on Wegovy through the stomach phase. But 4.3% of adults in the weight trials stopped because of digestive side effects, against 0.7% on placebo [1]. In the pooled analysis, 99.5% of digestive events on semaglutide were non-serious and 98.1% were mild to moderate [2].
One finding may reassure you if you're worried that feeling sick is the point. The same analysis found weight loss was similar in people with and without digestive side effects, and less than one percentage point of the extra weight loss was explained by them [2]. The post-hoc analysis does not establish nausea as a necessary sign of treatment response.
When nausea is a warning sign
Severe, lasting stomach pain, vomiting you can't stop, or signs of dehydration need prompt medical attention. Each one connects to a warning on the label [1].
| What you notice | What it could mean | What the label or Medication Guide says |
|---|---|---|
| Queasy after a dose increase, settling over days | Ordinary digestive side effect | Tell your provider if it's severe or won't go away |
| Severe stomach pain that won't go away, sometimes felt in the back, with or without vomiting | Possible pancreatitis | Stop Wegovy and call your provider right away |
| Upper stomach pain, fever, yellow skin or eyes, clay-colored stools | Possible gallbladder problem | Call your provider; see Wegovy and your gallbladder |
| Vomiting or diarrhea that won't stop, or you can't keep fluids down | Dehydration, which can harm the kidneys | Tell your provider right away; see Wegovy and fluids |
| Severe constipation with a swollen belly or vomiting | Rarely, a blocked bowel | Call your provider promptly |
Based on the pancreatitis, gallbladder, kidney and severe digestive warnings in the Wegovy prescribing information and Medication Guide [1]. The full safety picture is in is Wegovy safe.
What you can ask your prescriber
The dose schedule exists to limit these effects, so ask before changing anything yourself. The label leaves dose changes to your prescriber. Good questions to bring:
- Is what I'm feeling typical for this point in treatment?
- Should we change how my dose is going up?
- Is there anything you'd recommend for the nausea or constipation, given my other medicines?
- Which symptoms should make me call you right away?
The Medication Guide adds one line of its own: “It is important for you to drink fluids to help reduce your chance of dehydration. Tell your healthcare provider right away if you have nausea, vomiting, or diarrhea that does not go away” [1]. You can also report side effects to FDA's MedWatch program [4].
Some programs sell lower-than-label doses of GLP-1s to reduce nausea. The cited evidence does not establish that approach; the evidence gap is in microdosing GLP-1s. The full Wegovy side-effect list is in Wegovy side effects, and the tablet version is covered in oral semaglutide.